Give your opinion on a genetically modified medicine for the treatment of various types of advanced cancer
January 13, 2022
The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial testing the genetically modified oncolytic virus VSV-GP (BI 1831169), for the treatment of patients with various types of advanced cancer (solid tumours). The public consultation runs from 11 January 2022 to 10 February 2022.
For each clinical trial application for the use of a genetically modified organisms, the government organises a thirty-day public consultation, in accordance with the Royal Decree of 21 February 2005(link is external). As a citizen, you can give your opinion on this clinical trial application with the genetically modified medicinal product VSV-GP (BI 1831169) for the treatment of various types of advanced cancer (solid tumours).